Med-Surg: Chapter 21: Methicillin-Resistant Staphylococcus aureus (MRSA) Flashcards

1
Q

Staphylococcus aureus (S. aureus)

A
  • asymptomatic pathogen
  • normal bacterial flora of humans
  • colonized (the host carries the bacteria without active infection)
  • aerobic, gram-positive, non-sporulating (does not make spores capable of reproduction), coagulase-positive bacterium (produces the enzyme coagulase, which helps convert fibrinogen to fibrin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are the individualized colonized with Staphylococcus aureus?

A
  • nose
  • throat
  • axillae
  • toe webs
  • perineum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Interventions for the Decline in MRSA rates?

A

general infection control efforts

  • alcohol-based hand rubs
  • hand hygiene
  • efforts targeted at eliminating bloodstream infections
  • enhanced antimicrobial stewardship programs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Methicillin-resistant S. aureus is a result of what?

A

decades of unnecessary antibiotic use

  • community acquired
  • hospital acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Methicillin-resistant S. aureus resistant to?

A

all beta-lactam antibiotics including penicillin’s, cephalosporins, and carbapenems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors for Hospital acquired MRSA? (HAMRSA)

A
  • current/recent hospitalization
  • residing in long-term care facility
  • invasive procedures/ medical devices (urinary catheters or IV lines that create portal of entry)
  • recent antibiotic use
  • long-term broad-spectrum antibiotic therapy allowing bacteria to become resistant to a specific antibiotic
  • weakened immune system
  • comorbid conditions
  • dialysis devices
  • Gastrointestinal (GI) disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk Factors for Community acquired MRSA? (CAMRSA)

A

-less than 2 years of age
-Athletes
-IV drug abusers
-Men who have sex with men
-Military personnel
-Prison inmates
-People living in shelters
>risk factors are associated with close skin-to-skin contact, crowded living conditions, and poor hygiene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology of MRSA

A

because it is a coagulase bacterium, MRSA is coated with a fibrin wall that resists phagocytosis, making the bacterium more virulent, enabling it to protect itself from host defense mechanisms
-S. aureus destroys the active lactam ring in the penicillin molecule by secreting the enzyme beta-lactamase; this genetic mutation prevents the beta-lactam ring from binding to the bacterial cell thus, the agent cannot exert its antimicrobial effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endogenous pathogen

A

pathogen residing on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Exogenous Pathogen

A

outside the body sources

-the mode of transmission from an exogenous source is contaminated surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is MRSA found?

A

on humans

-can live on surfaces and humans for days to weeks; varying life span

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is MRSA transferred/spread?

A

can easily be transferred to the skin and other body areas, increasing risk for infection

ex: if a person is colonized with MRSA in the nose and wipes the nose with the hand and then touches an open wound, the bacteria can then be transferred to the wound and cause infection
- contact
- can be spread if an infected person touches the source of infection and then touches an object or surface
- easily spread in hospitals from patient to patient or from body part to body part on the unclean hands of healthcare personnel or improperly cleaned equipment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to prevent transmission?

A
  • proper hand hygiene
  • covering cuts and open wounds with bandages
  • bathe and shower regularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical Manifestations of Staph aureus

A
  • minor skin infections (pimples, abscesses, sties, and impetigo)
  • these are clinical manifestations if infected with the bacteria staph aureus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical Manifestations of MRSA: These happen when infected with MRSA infection

A
  • pneumonia
  • skin and soft tissue infections
  • surgical-site infections
  • bloodstream infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications

A
  • resistant to numerous antibiotics; difficult to treat
  • can cause widespread infections
  • increased morbidity and mortality rate
  • septic shock
  • osteomyelitis
  • untreated can lead to multisystem organ failure and death
17
Q

Medications to Treat MRSA

A
  • Vancomycin (Vancocin)
  • Linezolid (Zyvox)
  • Clindamycin (Cleocin) for CAMRSA
  • Sulfamethoxazole/Trimethoprim (Bactrim) for CAMRSA
18
Q

Methicillin-resistant S. Aureus modes of transmission ad how it infects the skin

A

transmitted via skin contact with a carrier and entering through breaks in the skin
-can be transmitted easily to the skin and other body areas
-transmitted by skin contact with a carrier and contact with contaminated items and surfaces
>MRSA infects the skin by entering minor scrapes or cuts; infection looks like a boil, a pimple, or spider bite; wound is very contagious, filled with the bacteria
-symptoms: swelling, pus/infection, painful, infection slow to heal

19
Q

Symptoms of MRSA infection

A
  • swelling
  • pus/infection
  • painful
  • slow to heal
20
Q

Medication: The Trough Level

A

blood sample drawn after a dose is given but immediately before the next dose
-monitored weekly to avoid toxic doses and maintain therapeutic levels

21
Q

Medication for MRSA: Vancomycin

A

antibiotic

  • administered IV or orally
  • trough levels drawn and monitored weekly to avoid toxic doses and maintain therapeutic levels
  • if trough levels high, can cause nephrotoxicity (kidney) and ototoxicity (ear)
  • weekly BUN and serum creatinine to assess kidney function b/c of nephrotoxicity
  • administer over 1 HOUR to avoid red man syndrome (red face & neck)
  • report signs of hypersensitivity, tinnitus, vertigo, or hearing loss
22
Q

Medications for MRSA: Linezolid

A

antibiotic

  • used to treat skin and soft tissue infections caused by MRSA
  • bacteriostatic (stop organism reproduction) against enterococci and staphylococci
  • IV or orally
  • given for 7 to 21 days depending on infection
  • if given for > 10 days, monitor CBC for myelosuppression (anemia, leukopenia, pancytopenia, and thrombocytopenia)
  • may cause diarrhea, nausea, and vomiting
  • can cause CNS reactions when taken with serotonergic psychiatric medications
  • avoid foods high in tyramine (aged cheeses, dried/processes meats, alcohol, soy sauce)
23
Q

Medications for MRSA: Clindamycin

A

antibiotics

  • treats CAMRSA (community acquired MRSA)
  • IV or orally
  • can cause diarrhea and C. diff
24
Q

Medications for MRSA: Sulfamethoxazole-trimethoprim (Bactrim)

A

antibiotic

  • treats CAMRSA (community acquired MRSA) skin and soft tissue infections
  • dosing adjusted with impaired renal function
  • can cause nausea, vomiting, loss of appetite
  • can cause sun-sensitivity (encourage sunscreen)
  • report signs of jaundice, somnolence (sleepiness), and confusion (can be a sign of fulminant hepatic necrosis)
  • stay hydrated to prevent renal stones while taking this medication